1. Zhu, Huang, Blum, Robert H, Bernareggi, Davide, Malmberg, Karl-Johan, Kaufman, Dan S. 2020. Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity. In Cell stem cell, 27, 224-237.e6. doi:10.1016/j.stem.2020.05.008. https://pubmed.ncbi.nlm.nih.gov/32531207/
2. Bernard, Pierre-Louis, Delconte, Rebecca, Pastor, Sonia, Nunes, Jacques, Guittard, Geoffrey. . Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity. In Journal for immunotherapy of cancer, 10, . doi:10.1136/jitc-2021-004244. https://pubmed.ncbi.nlm.nih.gov/35589278/
3. Jin, Jun, Mu, Yunmei, Zhang, Huimin, Weyand, Cornelia M, Goronzy, Jorg J. 2023. CISH impairs lysosomal function in activated T cells resulting in mitochondrial DNA release and inflammaging. In Nature aging, 3, 600-616. doi:10.1038/s43587-023-00399-w. https://pubmed.ncbi.nlm.nih.gov/37118554/
4. Miah, Mohammad Alam, Yoon, Cheol-Hee, Kim, Joonoh, Seong, Young-Rim, Bae, Yong-Soo. 2011. CISH is induced during DC development and regulates DC-mediated CTL activation. In European journal of immunology, 42, 58-68. doi:10.1002/eji.201141846. https://pubmed.ncbi.nlm.nih.gov/22002016/
5. Lakkavaram, Asha L, Maymand, Saeed, Naser, Wasan, Ward, Alister C, de Koning-Ward, Tania F. 2023. Cish knockout mice exhibit similar outcomes to malaria infection despite altered hematopoietic responses. In Frontiers in microbiology, 14, 1288876. doi:10.3389/fmicb.2023.1288876. https://pubmed.ncbi.nlm.nih.gov/38029163/
6. Shoger, Karsen E, Cheemalavagu, Neha, Cao, Yuqi M, Singh, Harinder, Gottschalk, Rachel A. 2021. CISH attenuates homeostatic cytokine signaling to promote lung-specific macrophage programming and function. In Science signaling, 14, eabe5137. doi:10.1126/scisignal.abe5137. https://pubmed.ncbi.nlm.nih.gov/34516753/
7. Boudin, Laurys, De Nonneville, Alexandre, Finetti, Pascal, Mamessier, Emilie, Bertucci, François. 2022. CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression. In Cancers, 14, . doi:10.3390/cancers14143356. https://pubmed.ncbi.nlm.nih.gov/35884417/
8. Takeshima, Hideyuki, Horie, Masafumi, Mikami, Yu, Nagase, Takahide, Yamauchi, Yasuhiro. 2018. CISH is a negative regulator of IL-13-induced CCL26 production in lung fibroblasts. In Allergology international : official journal of the Japanese Society of Allergology, 68, 101-109. doi:10.1016/j.alit.2018.08.005. https://pubmed.ncbi.nlm.nih.gov/30197185/